These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Results of planned in-vitro fertilization programming through the pre-administration of the oestrogen-progesterone combined pill. Cohen J; Debache C; Solal P; Serkine AM; Achard B; Boujenah A; Pez JP; Paris X; Robert J; Loffredo V Hum Reprod; 1987 Jan; 2(1):7-9. PubMed ID: 3106405 [TBL] [Abstract][Full Text] [Related]
23. The relative success of gonadotropin-releasing hormone analogue, clomiphene citrate, and gonadotropin in 1,099 cycles of in vitro fertilization. Dor J; Ben-Shlomo I; Levran D; Rudak E; Yunish M; Mashiach S Fertil Steril; 1992 Nov; 58(5):986-90. PubMed ID: 1426387 [TBL] [Abstract][Full Text] [Related]
24. One ovary or two: differences in ovulation induction, estradiol levels, and follicular development in a program for in vitro fertilization. Diamond MP; Wentz AC; Herbert CM; Pittaway DE; Maxson WS; Daniell JF Fertil Steril; 1984 Apr; 41(4):524-9. PubMed ID: 6423412 [TBL] [Abstract][Full Text] [Related]
25. Endocrine profile in serum and follicular fluid differs after ovarian stimulation with HP-hMG or recombinant FSH in IVF patients. Smitz J; Andersen AN; Devroey P; Arce JC; Hum Reprod; 2007 Mar; 22(3):676-87. PubMed ID: 17110397 [TBL] [Abstract][Full Text] [Related]
26. Impact of clomiphene citrate during ovarian stimulation on the luteal phase after GnRH agonist trigger. Derksen L; Tournaye H; Stoop D; Van Vaerenbergh I; Bourgain C; Polyzos NP; Haentjens P; Blockeel C Reprod Biomed Online; 2014 Mar; 28(3):359-68. PubMed ID: 24456700 [TBL] [Abstract][Full Text] [Related]
27. The importance of the FSH/LH ratio in ovarian stimulation therapy regime for in vitro fertilization. Bhat AM; Feichtinger W; Kemeter P Acta Eur Fertil; 1984; 15(6):449-53. PubMed ID: 6443053 [TBL] [Abstract][Full Text] [Related]
28. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment. Beckers NG; Macklon NS; Eijkemans MJ; Ludwig M; Felberbaum RE; Diedrich K; Bustion S; Loumaye E; Fauser BC J Clin Endocrinol Metab; 2003 Sep; 88(9):4186-92. PubMed ID: 12970285 [TBL] [Abstract][Full Text] [Related]
29. Ovulation induction in clomiphene-resistant anovulatory women: differential follicular response to purified urinary follicle-stimulating hormone (FSH) versus purified urinary FSH and luteinizing hormone. Hoffman DI; Lobo RA; Campeau JD; Tsai HM; Holmberg EA; Ono T; Frederick JJ; Platt LD; diZerega GS J Clin Endocrinol Metab; 1985 May; 60(5):922-7. PubMed ID: 3920235 [TBL] [Abstract][Full Text] [Related]
30. Enhanced follicular recruitment in an in vitro fertilization program: clomiphene alone versus a clomiphene/human menopausal gonadotropin combination. Quigley MM; Schmidt CL; Beauchamp PJ; Pace-Owens S; Berkowitz AS; Wolf DP Fertil Steril; 1984 Jul; 42(1):25-33. PubMed ID: 6427027 [TBL] [Abstract][Full Text] [Related]
31. [Menstrual cycle stimulation in the in vitro fertilization program--effects on estrogen and progesterone receptors of the endometrium]. Seliger E; Schöneich C; Kaltwasser P; Bergleiter R; Buchmann J; Rothe K Zentralbl Gynakol; 1988; 110(23):1499-506. PubMed ID: 3149099 [TBL] [Abstract][Full Text] [Related]
32. [Clomiphene as an inducer of multiple follicular growth]. García Luna A; González Diddi M; Murrieta S; Guzmán F; Alvarado Durán A Ginecol Obstet Mex; 1989 Mar; 57():76-81. PubMed ID: 2487307 [TBL] [Abstract][Full Text] [Related]
33. Number of follicles, oocytes and embryos in human in vitro fertilization is relative to serum estradiol and progesterone patterns during different types of ovarian hyperstimulation. Suchanek E; Huderer K; Dobec D; Hlavati V; Simunic V; Grizelj V Eur J Obstet Gynecol Reprod Biol; 1994 Aug; 56(2):121-7. PubMed ID: 7805963 [TBL] [Abstract][Full Text] [Related]
34. Antiestrogenic effect of clomiphene citrate in a multiple follicular stimulation protocol. Diamond MP; Maxson WS; Vaughn WK; Osteen KG; Wentz AC J In Vitro Fert Embryo Transf; 1986 Apr; 3(2):106-9. PubMed ID: 3084690 [TBL] [Abstract][Full Text] [Related]
35. [Ovarian stimulation and corpus luteum function in human in vitro fertilization and embryo transfer]. Hara S Nihon Sanka Fujinka Gakkai Zasshi; 1987 Nov; 39(11):2043-50. PubMed ID: 3123577 [TBL] [Abstract][Full Text] [Related]
36. Comparison of four different ovarian stimulation protocols in an in vitro fertilisation & embryo transfer programme. Hinduja I; Mehta R; Gopalkrishnan K; Puri CP; Shah J; Singh V; Kumar TC Indian J Med Res; 1991 Dec; 94():405-12. PubMed ID: 1774091 [TBL] [Abstract][Full Text] [Related]
37. Induction of follicular growth, ovulation and luteinization in the human ovary. Edwards RG; Steptoe PC J Reprod Fertil Suppl; 1975 Apr; (22):121-63. PubMed ID: 1058970 [TBL] [Abstract][Full Text] [Related]
38. In vitro fertilisation. A review of drug therapy and clinical management. Jennings JC; Moreland K; Peterson CM Drugs; 1996 Sep; 52(3):313-43. PubMed ID: 8875126 [TBL] [Abstract][Full Text] [Related]
39. The luteal phase after hyperstimulation for in vitro fertilization. Gronow MJ; Martin MJ; Hay D; Moro D; Brown JB Ann N Y Acad Sci; 1985; 442():391-401. PubMed ID: 3160279 [TBL] [Abstract][Full Text] [Related]
40. Ovarian stimulation of IVF patients: effects of the reversible hypogonadotrophic state induced by GnRH agonist. Crosignani PG; Ragni G; Lombroso GC; Scarduelli C; De Lauretis L; Caccamo A; Dalprà L; Cavioni V; Cristiani C; Wyssling H Hum Reprod; 1988 Oct; 3 Suppl 2():39-41. PubMed ID: 3147991 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]